SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,157.20 -234.19
( -0.31%)

Global Indices

Nasdaq

51,722.16 -517.42
(-0.99%)

Dow Jones

7,429.53 -90.43
(-1.20%)

Hang Seng

66,278.94 163.34
(0.25%)

Nikkei 225

10,630.89 -86.08
(-0.80%)

Forex

USD-INR

96.48 0.17
(0.18%)

EUR-INR

110.06 0.16
(0.15%)

GBP-INR

129.05 -0.06
(-0.05%)

JPY-INR

0.59 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sameera Agro and Infra Ltd

Industry : Food - Processing - Indian

BSE Code

ISIN Demat

Book Value()

91892

INE0PZA01015

23.0413609

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SAIFL

1.79

29.77

EPS(TTM)

Face Value()

Div & Yield %

2.8

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

76,157.20 -234.19 ( -0.31%)

51,722.16 -517.42 (-0.99%)

7,429.53 -90.43 (-1.20%)

66,278.94 163.34 (0.25%)

10,630.89 -86.08 (-0.80%)

96.48 0.17 (0.18%)

110.06 0.16 (0.15%)

129.05 -0.06 (-0.05%)

0.59 0.00 (0.00%)